| 臺北醫學大學 |
2001 |
用於治療巴金森氏症之新穎二及三胜 太仿擬化合物
|
王惠珀; Wang HP; Lee JS; Tsai MC; Lu HHHu OYP; Lo WL |
| 臺北醫學大學 |
2001 |
Optimization of drug in vivo activity via pharmacokinetic studies.
|
王惠珀; Wang HP |
| 國立臺灣大學 |
2000-12 |
Preparation and antitumor activities of beta-azatyrosinamides.
|
Wang, HP; Wu, MF; Shew, JY; Lee, O; Lee, SJ; Sung, CH. |
| 臺北醫學大學 |
2000 |
Neue Azatyrosin-Analogs and the process of preparation thereof.
|
王惠珀; Wang HP; Lee On; Shew JY; Lee SJ |
| 臺北醫學大學 |
2000 |
Preparation and antitumor activities of b-azatyrosinamides.
|
王惠珀; Wang HP; Wu MF; Shu CY; Lee O; Lee SJ; Sung CH |
| 臺北醫學大學 |
2000 |
D-Phenylglycine-L-dopa as slow-release prodrug of dopamine.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (I): Anti-Parkinsonism Effect of D-Phenylglycine-L-dopa and L-Dopa-D-Phenylglycine after Oral Administration.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Aminoacyl Antraquinones as potential antineoplastic agents.
|
王惠珀; Lee O; LeeLT; Wu HS; Wang HP |
| 臺北醫學大學 |
1999 |
Selective cytotoxicity of novel Azatyrosinamides.
|
王惠珀; Lee O; Li YI; Hwang CF; Wang HP |
| 臺北醫學大學 |
1999 |
b-Azatyrosinamides: Synthesis and Selective cytotoxicity
|
王惠珀; Lee O; Wang HP |
| 臺北醫學大學 |
1999 |
Synthesis and inhibition of pyrimidine analogues on bovine liver dihydrofolate redutase.
|
王惠珀; Lee O; Wu HS; Liu WC; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (II): CNS Bioavailability of D-Phenylglycine-L-dopa in Rats.
|
王惠珀; Lee SN; Wang HP |
| 臺北醫學大學 |
1999 |
Intestinal Oligopeptide Transporter (PepT1) as a Drug Delivery System: D-Phenylglycine as a Seeing-eye Dog for L-Dopa Transport through PepT1.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Selective cytotoxicity of novel Azatyrosinamides.
|
王惠珀; Lee O; Li YI; Hwang CF; Wang HP |
| 臺北醫學大學 |
1999 |
Synthesis and inhibition of pyrimidine analogues on bovine liver dihydrofolate redutase.
|
王惠珀; Lee O; Wu HS; Liu WC; Wang HP |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (III): Species Differences between Rats and Rabbits in the Pharmacokinetics of D-Phenylglycine-L-dopa.
|
王惠珀; Luo WW; Fan YB; Wang HP; |
| 臺北醫學大學 |
1999 |
Drug Delivery Through Dipeptide Transporter (II): Species Differences between Rats and Rabbits in the Pharmacokinetics of D-Phenylglycine-L-dopa.
|
王惠珀; Luo WW; Fan YB; Wang HP; |
| 臺北醫學大學 |
1999 |
Intestinal Oligopeptide Transporter (PepT1) as a Drug Delivery System: D-Phenylglycine as a Seeing-eye Dog for L-Dopa Transport through PepT1.
|
王惠珀; Wang HP |
| 臺北醫學大學 |
1999 |
Primary sclerosing cholangitis in a child.
|
朱娟秀; Lin WT; Lin SJ; Ni YH; Chen HL; Wang HP; Chu JS; Chang MH; |
| 臺北醫學大學 |
1998 |
Methods in the Preparation of D-Phenylglycine-containing Cefotaxime Double Esters (Cefotaxime-PG).
|
王惠珀; Sun CH; Wang HP |
| 國立臺灣大學 |
1998 |
Helicobacter pylori infection and age on the development of intestinal metaplasia: a multiple logistic regression analysis
|
Wang, CC; Wu, MS; Wang, HH; Wang, HP; Lee, WC; Shun, CT; Lin, JT |
| 國立臺灣大學 |
1998 |
Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia
|
Wu, MS; Shun, CT; Lee, WC; Chen, CJ; Wang, HP; Lee, WJ; Sheu, JC; Lin, JT |
| 國立臺灣大學 |
1998 |
Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer
|
Wu, MS; Shun, CT; Lee, WC; Chen, CJ; Wang, HP; Lee, WJ; Sheu, JC; Lin, JT |
| 臺北醫學大學 |
1997 |
Inhibition of azatyrosine analogues on the growth of Ras-transformed tumor cells.
|
王惠珀; Lee O; Shu CY; Lee SJ; Wang HP |
| 臺北醫學大學 |
1997 |
2-Amino-4-methyl-5-(4-substituted-1-piperazinyl) pyrimidin-6-ones, preparation and Use.
|
王惠珀; Wang HP; Bai TS |
